Search Results - Roger Schibli
- Showing 1 - 20 results of 56
- Go to Next Page
-
1
-
2
Antibody Conjugates: From Heterogeneous Populations to Defined Reagents by Patrick Dennler, Eliane Fischer, Roger Schibli
Published 2015-08-01
Article -
3
-
4
-
5
-
6
Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4 by Simon A. M. Kaeppeli, Roger Schibli, Thomas L. Mindt, Martin Behe
Published 2019-05-01
Article -
7
-
8
-
9
-
10
-
11
-
12
-
13
Liquid Chromatography ICP-MS to Assess the Stability of <sup>175</sup>Lu- and <sup>nat</sup>Ga-Based Tumor-Targeting Agents towards the Development of <sup>177</sup>Lu- and <sup>68... by Rahel H. Wallimann, Heloïse Hensinger, Cristina Müller, Roger Schibli, Rainer Kneuer, Patrick Schindler
Published 2024-02-01
Article -
14
Targeted Radiotherapeutics from 'Bench-to-Bedside' by Cristina Müller, Martin Béhé, Susanne Geistlich, Nicholas P. van der Meulen, Roger Schibli
Published 2020-12-01
Article -
15
-
16
18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease—A Proof-of-Concept Study by Janine Schniering, Martina Benešová, Martina Benešová, Matthias Brunner, Stephanie Haller, Susan Cohrs, Thomas Frauenfelder, Bart Vrugt, Carol Feghali-Bostwick, Roger Schibli, Roger Schibli, Oliver Distler, Cristina Müller, Cristina Müller, Britta Maurer
Published 2019-11-01
Article -
17
DOTA-functionalized polylysine: a high number of DOTA chelates positively influences the biodistribution of enzymatic conjugated anti-tumor antibody chCE7agl. by Jürgen Grünberg, Simone Jeger, Dikran Sarko, Patrick Dennler, Kurt Zimmermann, Walter Mier, Roger Schibli
Published 2013-01-01
Article -
18
Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [18F]PSS232 in the Rat... by Adrienne Müller Herde, Silvan D. Boss, Yingfang He, Roger Schibli, Linjing Mu, Simon M. Ametamey
Published 2018-08-01
Article -
19
-
20